Relation between tumor treating fields usage rate ≥75% for the first 3 months and progression-free survival in patients with newly diagnosed WHO grade 4 gliomas
TTFields use rate ≥75% in the first 3 months was significantly associated with improved PFS. There was a tendency for OS to be extended. Further analysis with a larger number of cases is required.
Authors
- Fumiharu Ohka (ORCID: https://orcid.org/0000-0002-5569-5626)
- Yuichi Hirose (ORCID: https://orcid.org/0000-0002-1305-1830)
- Noriyuki Nakayama (ORCID: https://orcid.org/0000-0003-3083-0964)
- Tetsuyoshi Horiuchi (ORCID: https://orcid.org/0000-0001-5620-510X)
- Ryuta Saito (ORCID: https://orcid.org/0000-0002-2484-1360)
- Shinichiro Koizumi (ORCID: https://orcid.org/0000-0003-1104-6824)
- Hiroshi Yamada (ORCID: https://orcid.org/0000-0001-5560-0319)
- Koichi Mitsuya (ORCID: https://orcid.org/0000-0001-8956-5427)
- Masashi Kinoshita (ORCID: https://orcid.org/0000-0002-2148-8231)
- Shigeo Ohba (ORCID: https://orcid.org/0000-0003-4575-0238)
- Ken‐ichiro Kikuta (ORCID: https://orcid.org/0000-0001-9275-2872)
- Yu Fujii (ORCID: https://orcid.org/0000-0002-9478-6109)
- Mitsutoshi Nakada (ORCID: https://orcid.org/0000-0001-9419-6101)
- Takahiro Yamauchi
- Yotaro Kitano (ORCID: https://orcid.org/0000-0003-1344-2548)
- Shoichi Deguchi (ORCID: https://orcid.org/0000-0003-2424-2314)
- Takahiro Nakura
- Kazuhiko Kurozumi (ORCID: https://orcid.org/0000-0002-6942-9919)
- Hidenori Suzuki (ORCID: https://orcid.org/0000-0002-3156-0591)
- Tsuyoshi Izumo (ORCID: https://orcid.org/0000-0001-8778-2698)
- Satoshi Kuroda
- Shigeru Miyachi (ORCID: https://orcid.org/0000-0003-2703-1379)
- Mitsuhito Mase (ORCID: https://orcid.org/0000-0002-7219-7450)
- Takahiro Tomita
Institutions
- Kanazawa University (JP)
- University of Fukui (JP)
- Fukui University of Technology (JP)
- Shinshu University (JP)
- Fujita Health University (JP)
- Aichi Medical University (JP)
- Kanazawa Medical University (JP)
- Mie University (JP)
- Hamamatsu University School of Medicine (JP)
- Nagoya City University (JP)
- Shizuoka Cancer Center (JP)
- Toyama University Hospital (JP)
- Gifu University (JP)
- University of Toyama (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf203
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development